Sweden

 

Attendo increases market share in Sweden with 120 Team Olivia units

Pan-Nordic care group Attendo has acquired 120 facilities from Team Olivia, a rival Nordic care group. The acquisition will boost Attendo's already-dominant market share in Sweden’s for-profit disability, personal and family, and home care sectors. We speak to the company’s investor relations director to find out more. 
January 19, 2024

New AI act could stifle EU innovation – but benefit the UK

After 38 hours of deliberation, a long-awaited deal has finally been reached in Brussels. HBI speaks to three market experts to understand what the AI Act - the comprehensive European framework for AI innovation and regulation - could mean for the future of healthcare in Europe.
December 15, 2023

Interview: Kalle Conneryd-Lungren, chief operating officer, Kry

Sweden-based telehealth firm Kry is growing fast in France. After a series of layoffs and a German exit, HBI catches up with COO Kalle Conneryd-Lungren to talk about the appeal of the French market, profitability in the Nordics, and Kry's plans in general.
November 10, 2023

Panic rush to do deals ahead of Lauterbach reforms

HBI hears that a glut of M&A deals are being rushed through, with panicking investors and operators competing for buyers before Federal Health Minister Karl Lauterbach's controversial reforms pass - though it remains unclear exactly what those reforms will be. HBI asks whether the panic is merited, just how low have multiples dropped, and who will benefit from this?
September 29, 2023

HBI 2023: Managing your costs in challenging times

Rising costs from inflation, wages, and energy are indiscriminately hitting the health care sector and despite government support packages being pledged, the road ahead looks arduous. So how do providers control costs, and what are the strategies to keep costs at bay?
July 15, 2023

Humana wins appeal against licence revocation

Pan-Nordic care company Humana Group has succeeded with an appeal against the decision by Sweden's health care inspectorate to revoke its licence. The company's share price shot up 48% after the announcement.
July 5, 2023

Stockholm’s plan to reduce patient choice may increase queues and private pay

The government of the region of Stockholm in Sweden wants to reduce the choice of health care providers patients currently enjoy in secondary care. The government says the move will save money, but private providers are concerned it will be damaging to patient access and efficiency, and could force more people to take out private insurance.
June 16, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us